Rockefeller Capital Management’s BridgeBio Pharma BBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $689K | Sell |
|
|||||
|
2025
Q2 | $1.67M | Buy |
|
|||||
|
2025
Q1 | $596K | Sell |
|
|||||
|
2024
Q4 | $1.13M | Buy |
|
|||||
|
2024
Q3 | $1.05M | Buy |
|
|||||
|
2024
Q2 | $936K | Sell |
|
|||||
|
2024
Q1 | $1.27M | Sell |
|
|||||
|
2023
Q4 | $1.68M | Sell |
|
|||||
|
2023
Q3 | $1.11M | Sell |
|
|||||
|
2023
Q2 | $1.01M | Buy |
|
|||||
|
2023
Q1 | $815K | Buy |
|
|||||
|
2022
Q4 | $345K | Sell |
|
|||||
|
2022
Q3 | $500K | Sell |
|
|||||
|
2022
Q2 | $606K | Sell |
|
|||||
|
2022
Q1 | $915K | Sell |
|
|||||
|
2021
Q4 | $18.5M | Buy |
|
|||||
|
2021
Q3 | $39.2M | Buy |
|
|||||
|
2021
Q2 | $50.7M | Buy |
|
|||||
|
2021
Q1 | $50.5M | Buy |
|
|||||
|
2020
Q4 | $55.3M | Buy |
|